Keyphrases
Low-intensity Pulsed Ultrasound (LIPUS)
100%
Focused Ultrasound
88%
Blood-brain Barrier Disruption
72%
Evans Blue
40%
Ultrasound Contrast Agents
34%
Tumor
31%
Ultrasound
30%
Transcranial Ultrasound Stimulation
29%
Rat Model
27%
Blood-brain Barrier
27%
Pulsed High-intensity Focused Ultrasound
25%
Microbubbles
21%
Ordinal Optimization
20%
Brain-derived Neurotrophic Factor
18%
Lipopolysaccharide-induced
18%
Transcranial Focused Ultrasound (tFUS)
17%
Neuroinflammation
17%
Ultrasound Treatment
16%
Glioma
16%
Glioblastoma multiforme
16%
Ultrasound Exposure
15%
Neurotrophic Factors
15%
Brain Injury
15%
Alzheimer's Disease
15%
Neuroprotective Effect
15%
Good Enough
14%
Good Enough Solution
14%
Functional Change
12%
Solution Space
12%
Magnetic Resonance Imaging
12%
Computational Efficiency
12%
Traumatic Brain Injury
11%
Protective Effect
11%
Solution Quality
11%
Pegylated Liposomal Doxorubicin
11%
Pharmacokinetic Analysis
11%
Abdominal Ultrasound
11%
Specific Peptide
11%
Atherosclerotic Plaque
11%
Lipopolysaccharide
10%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
10%
Pharmacokinetics
10%
Brain Tumor
10%
Pulsed Focused Ultrasound
10%
Peak Systolic Velocity
10%
High-intensity Focused Ultrasound
9%
Quality Efficiency
9%
Booking Limits
9%
Optimization Approach
9%
Antitumor Effect
9%
Pharmacology, Toxicology and Pharmaceutical Science
Blood-Brain Barrier
69%
Neoplasm
44%
Evans Blue
28%
Echo Contrast Medium
24%
Rat Model
24%
Lipopolysaccharide
23%
Glioblastoma
19%
Pharmacokinetics
19%
Nervous System Inflammation
18%
Brain Derived Neurotrophic Factor
17%
Neurotrophic Factor
16%
Neuroprotective Agent
16%
Inflammation
16%
Extravasation
14%
Intracranial Tumor
14%
Traumatic Brain Injury
12%
Doxorubicin
11%
Chemotherapy
10%
Mouse Model
10%
Memory Disorder
9%
Fluorine 18
8%
Protein Kinase B
8%
Parkinson's Disease
7%
Chitosan
7%
Tumor Growth
7%
Brain Disease
6%
Liposome
6%
Western Blot
6%
Tight Junction Protein
6%
Lipopolysaccharide-Induced Neuroinflammation
6%
Neuroprotection
6%
Malignant Neoplasm
6%
Tumor Model
5%
Contrast Medium
5%
Binding Protein
5%
Oxidopamine
5%
Phosphotransferase
5%
Toll Like Receptor 4
5%
Targeted Drug Delivery
5%
Demyelination
5%
Tropomyosin
5%
Neuroscience
Blood Brain Barrier
82%
Contrast Medium
30%
Brain-Derived Neurotrophic Factor
25%
Neuroprotective Agent
23%
Neurotrophic Factor
22%
Pharmacokinetics
19%
Lipopolysaccharide
19%
Intracranial Tumor
17%
Alzheimer's Disease
15%
Brain Injury
12%
In Vivo
12%
Neurotrauma
12%
Traumatic Brain Injury
12%
Protein Expression
11%
Memory Disorder
11%
Doxorubicin
11%
Brain Disease
11%
Staining Technique
11%
Magnetic Resonance Imaging
10%
Programmed Cell Death
10%
Western Blot
9%
Protein Kinase B
9%
Microglia
8%
Glioblastoma Multiforme
8%
Astrocyte
8%
Parkinson's Disease
7%
Fluorine-18
7%
Remyelinization
7%
Multiple Sclerosis
7%
Microdialysis
7%
Magnetic Resonance Imaging
7%
Hippocampus
7%
Neuromodulation
6%
Single-Photon Emission Computed Tomography
6%
Oxidopamine
6%
Neuroprotection
6%
Cyclic Adenosine Monophosphate
5%
Protein Binding
5%
Response Element
5%
Kinase
5%
TLR 4
5%
Substantia Nigra Pars Compacta
5%
Tight Junction Protein
5%
Tropomyosin
5%